Application and Prospects of Artificial Intelligence Technology in Early Screening of Chronic Obstructive Pulmonary Disease at Primary Healthcare Institutions in China

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2024 Report; 2024. Available from: https://goldcopd.org/2024-gold-report/. Accessed May 10, 2024.
   Google Scholar
• Meghji J, Mortimer K, Agusti A, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397(10277):928–940. PMID: 33631128. doi:10.1016/S0140-6736(21)00458-X
   PubMed Web of Science ®Google Scholar
• Zhong NS, Wang C, Yao WZ, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population⁃based survey. Am J Respir Crit Care Med. 2007;176(8):753⁃760.
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross ⁃ sectional study. Lancet. 2018;391(10131):1706⁃1717.
   Web of Science ®Google Scholar
• Chen M, Ye K, Xu Z, et al. Current situation and prospect of chronic obstructive pulmonary disease community management in China. Chin Gen Pract. 2020;23(3):251–256. doi:10.12114/j.issn.1007-9572.2019.00.756
   Google Scholar
• Topalovic M, Das N, Burgel PR, et al. Pulmonary function study investigators; pulmonary function study investigators: Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. Eur Respir J. 2019;53(4):1801660. PMID: 30765505. doi:10.1183/13993003.01660-2018
   PubMed Web of Science ®Google Scholar
• Yang Y, Li W, Guo Y, et al. Early COPD risk decision for adults aged from 40 to 79 years based on lung radiomics features. Front Med Lausanne. 2022;9:845286. PMID: 35530043; PMCID: PMC9069013. doi:10.3389/fmed.2022.845286
   PubMed Web of Science ®Google Scholar
• Zhang L, Jiang B, Wisselink HJ, et al. COPD identification and grading based on deep learning of lung parenchyma and bronchial wall in chest CT images. Br J Radiol. 2022;95(1133):20210637. PMID: 35143286. doi:10.1259/bjr.20210637
   PubMed Web of Science ®Google Scholar
• Wang WY. To explore the diagnostic value of artificial intelligence robot pre-diagnostic risk assessment and radiomics in chronic obstructive pulmonary disease [Master’s thesis]. Dalian Medical University; 2023.
   Google Scholar
• Chinese Medical Association, Chinese Medical Association Press, General Practice Branch of Chinese Medical Association, Pulmonary Function Professional Group of Chinese Medical Association Respiratory Diseases Branch, Editorial Committee of Chinese Journal of General Practitioners, Expert Group for Writing Primary Diagnosis and Treatment Guidelines of Respiratory System Diseases. General guidelines for routine pulmonary function tests (2018). Chin J Gen Practit. 2019;18(6):511–518. doi:10.3760/cma.j.issn.1671-7368.2019.06.003
   Google Scholar
• Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285–295. doi:10.1159/000090142
   PubMed Web of Science ®Google Scholar
• Martinez F, Mannino D, Leidy NK, et al. A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(6):748–756. doi:10.1164/rccm.201603-0622OC
   PubMed Web of Science ®Google Scholar
• Schoepf UJ, Bruening RD, Hong C, et al. Multislice helical CT of focal and diffuse lung disease: comprehensive diagnosis with reconstruction of contiguous and high-resolution CT sections from a single thin-collimation scan. AJR Am J Roentgenol. 2001;177(1):179–184. PMID: 11418423. doi:10.2214/ajr.177.1.1770179
   PubMed Web of Science ®Google Scholar
• Agusti A, Sin DD. Biomarkers in COPD. Clin Chest Med. 2014;35(1):131–141.
   PubMed Web of Science ®Google Scholar
• Leidy NK, Martinez FJ, Malley KG, et al. Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment? Int J Chronic Obstr. 2018;13:1901–1912. doi:10.2147/COPD.S152226
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liu S, Lv J, et al. Design of a survey method for the prevalence of chronic obstructive pulmonary disease in China. Chin J Epidemiol. 2006;27(9):814–818.
   Google Scholar
• Zhou YM, Chen SY, Tian J, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis. 2013;17(12):1645–1651. doi:10.5588/ijtld.12.0995
   PubMed Web of Science ®Google Scholar
• Yang X, Yao M, Yin D, et al. Comparative study on chronic obstructive pulmonary disease screening tools in primary healthcare institutions in Beijing, China. Int J Chron Obstruct Pulmon Dis. 2023;18:1773–1781. PMID: 37608835; PMCID: PMC10441650. doi:10.2147/COPD.S419550
   PubMed Web of Science ®Google Scholar
• Kaplan A, Cao H, FitzGerald JM, et al. Artificial intelligence/machine learning in respiratory medicine and potential role in asthma and COPD diagnosis. J Allergy Clin Immunol Pract. 2021;9(6):2255–2261. PMID: 33618053. doi:10.1016/j.jaip.2021.02.014
   PubMed Web of Science ®Google Scholar
• Topalovic M, Das N, Burgel P-R, et al. Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. Eur Respir J. 2019;2019:1.
   Google Scholar
• Fischer AM, Varga-Szemes A, Van assen M, et al. Comparison of artificial intelligence-based fully automatic chest CT emphysema quantification to pulmonary function testing. AJR Am J Roentgenol. 2020;214(5):1065–1071. PMID: 32130041. doi:10.2214/AJR.19.21572
   PubMed Web of Science ®Google Scholar
• Li Z, Huang K, Liu L, et al. Early detection of COPD based on graph convolutional network and small and weakly labeled data. Med Biol Eng Comput. 2022;60(8):2321–2333. doi:10.1007/s11517-022-02589-x
   PubMed Web of Science ®Google Scholar
• Zafari H, Langlois S, Zulkernine F, Kosowan L, Singer A. AI in predicting COPD in the Canadian population. Biosystems. 2022;211:104585. PMID: 34864143. doi:10.1016/j.biosystems.2021.104585
   PubMed Web of Science ®Google Scholar
• Sunjaya AP, Ansari S, Jenkins CR. A systematic review on the effectiveness and impact of clinical decision support systems for breathlessness. Npj Primary Care Respirat Med. 2024. doi:10.1038/s41533-022-00291-x
   Web of Science ®Google Scholar
• Deshpande R, Koester C, Singanallur P, et al. Artificial intelligence as a predictive tool to identify patients with COPD at high risk for 30-day readmission. Chest. 2021;160(4):A1409. doi:10.1016/j.chest.2021.07.1289
   Web of Science ®Google Scholar
• Davies HJ, Bachtiger P, Williams I, et al. Wearable In-Ear PPG: detailed respiratory variations enable classification of COPD. IEEE Trans Biomed Eng. 2022;69(7):2390–2400. PMID: 35077352. doi:10.1109/TBME.2022.3145688
   PubMed Web of Science ®Google Scholar
• Voigt P, Von Dem Bussche A. The eu general data protection regulation (gdpr). A Practical Guide. 2017;10(3152676):10–5555.
   Google Scholar
• Cheng Xiao. On the personal information processing rules in China’s personal information protection law. Tsinghua Law Rev. 2021;15(3):55–73.
   Google Scholar
• Guifeng L, Bingying R, Qiong L. Strengthening data security protection and enhancing data governance capabilities: an interpretation of the draft ‘data security law of the People’s Republic of China’. J Agricult Lib Informat Sci. 2021;33(4):4–13.
   Google Scholar
• Tong R, Jiahui Q, Zhixing Z, et al. Medical data governance - building a high-quality medical big data intelligent analysis data foundation. Big Data. 2019;5(1):12–24.
   Google Scholar
• Cheplygina V, Pena IP, Pedersen JH, et al. Transfer learning for multicenter classification of chronic obstructive pulmonary disease. IEEE J Biomed Health Inform. 2018;22(5):1486–1496. doi:10.1109/JBHI.2017.2769800
   PubMed Web of Science ®Google Scholar
• Wang H, Fu T, Du Y, et al. Scientific discovery in the age of artificial intelligence. Nature. 2023;620(7972):47–60. PMID: 37532811. doi:10.1038/s41586-023-06221-2
   PubMed Web of Science ®Google Scholar
• Alcázar-Navarrete B, Trigueros JA, Riesco JA, Campuzano A, Pérez J. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: ”the ESPIRAL-ES study”. Int J Chron Obstruct Pulmon Dis. 2018;13:1115–1124. PMID: 29692606; PMCID: PMC5901135. doi:10.2147/COPD.S158031
   PubMed Web of Science ®Google Scholar
• Jayakumar S, Sounderajah V, Normahani P, et al. Quality assessment standards in artificial intelligence diagnostic accuracy systematic reviews: a meta-research study. Npj Digital Med. 2022;5(1):11. doi:10.1038/s41746-021-00544-y
   PubMed Web of Science ®Google Scholar
• Chaddad A, Peng J, Xu J, Bouridane A. Survey of Explainable AI Techniques in Healthcare. Sensors. 2023;23(2):634. PMID: 36679430; PMCID: PMC9862413. doi:10.3390/s23020634
   PubMed Web of Science ®Google Scholar